According to KalVista Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -HK$1.15 B. In 2023 the company made an earning of -HK$0.97 B a decrease over its 2022 earnings that were of -HK$0.83 B.The earnings displayed on this page is the company's Pretax Income.